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Dengue is one of the most serious and prevalent
mosquito-borne viral threats to humans worldwide
[1,2]. Infection with dengue virus (DV) generally
leads to fever, headache, pain in various parts of the
body, prostration, rash, lymphadenopathy, leukopenia
and more seriously, dengue hemorrhagic fever (DHF),
which can progress to dengue shock syndrome (DSS)
and death [3]. Dengue viruses, of the genus Flavivirus,
are classified into four antigenically distinct serotypes
(dengue 1–4) [3]. They have a single-stranded, positive
sense RNA genome of about 11,000 nucleotides [4]. To
date, dengue-3 has been classified into five genotypes
(I–V) by phylogenetic analysis based on different
viral gene regions, including the envelope gene and
prM/M gene. The same grouping results were
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Dengue virus serotype 3 (dengue-3) has been classified into five genotypes (I–V) by phylogenetic
analysis based on different viral genes. To investigate the genetic variability and evolutionary
character of the dengue-3 isolates in southern Taiwan from 2005 to 2006, we analyzed the 290 nu-
cleotides of the core (C) gene of 12 dengue-3 isolates and compared them with the published C gene
sequences of global dengue-3 strains available in GenBank, including four isolates from 1998 and
one isolate from 1999, from Taiwan. The dengue-3 viruses from 2005 to 2006 were not from con-
tinuous spread of an epidemic strain or re-emergence of the 2005 strains in the 2-year period because
there was a 5.4–6.2% difference in the 290 nucleotides of the C gene and different genotypes bet-
ween the 2005 and 2006 strains. Most of the nucleotide changes, compared with a prototype
dengue-3 virus, H87, occurred in the third codon position and were non-synonymous mutations
occurring naturally in the C gene. In addition, there was no consistent difference in the 290
nucleotides of the C gene between eight dengue fever and two dengue hemorrhagic fever isolates
from 2006. The phylogenetic analysis indicates that the isolates from the 1998, 1999 and 2006 Taiwan
dengue-3 epidemics are phylogenetically related and belong to genotype III. It was noted that the
2005 Taiwan dengue-3 isolates belong to another genotype. This molecular epidemiology study of dengue-
3 viruses in Taiwan helps to elucidate whether there is a continuation of outbreaks in consecutive
years, re-emergence of endemic dengue virus, or introduction of strains from other countries.
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obtained when analyzing different genes of dengue-3
viruses [5–7].
In Taiwan, historical epidemics of dengue in 1902,
1915, 1922, 1927, 1931 and 1942−1943 have been doc-
umented. After a 37-year period without dengue cases
from 1943 to 1981, a dengue-2 outbreak occurred in
the Liu Chiu District in 1981 [8]. Since the 1987 out-
break of dengue-1 infections, cases of dengue infection
have been reported every year. Cases of dengue-3 infec-
tion were reported in 1988, 1991–92, 1994–96, 1998,
1999, 2001, 2005 and 2006 [9,10]. Silent transmission
of dengue viruses in Taiwan has also been reported
[11]. However, dengue virus strains may be introduced
into Taiwan with increasing international travel.
Nucleotide sequence analysis of DV was used to
define genetic variation between strains of the same
serotype, follow geographical movement of the strains,
and determine the evolutionary origin of epidemic
dengue viruses [12–16]. To investigate the genetic
variability and evolutionary character of the dengue-3
strains isolated in southern Taiwan from 2005 to
2006, we analyzed the 290 nucleotides of the core (C)
gene of 12 dengue-3 isolates and compared them
with the published sequences of global dengue-3
strains available in GenBank, including four isolates
from 1998 and one isolate from 1999, from Taiwan.
MATERIALS AND METHODS
Serum specimens
Serum specimens were collected from patients clini-
cally suspected of DV infection in two Kaohsiung
hospitals in 2005 and 2006. These serum samples were
separated and stored at –80°C until use. The clinical
characteristics of these patients, including isolate des-
ignation, year of isolation, clinical status, fever and
skin rash, are shown in Table 1. The definition of
dengue fever (DF) and DHF were made according 
to the WHO clinical definition [17]. These specimens
were all confirmed as dengue-3 infection by culture
in C6/36 cell, reverse transcription–polymerase chain
reaction (RT-PCR) and serologic methods (ELISA—
IgG and IgM). All cases were considered to be indige-
nous according to the patient’s history because none
of these patients or their families had a history of
travel to other countries within the previous 2 weeks.
Nested RT-PCR and sequencing
RNA was extracted from the patient’s serum using
the QIAamp viral RNA purification kit according to
the manufacturer’s instructions (Qiagen, Chatsworth,
CA, USA). The outer primers D1 (5-ATCAATAT-
GCTGAAACGCGCGAGAAACCG-3) and D2 (5-
TTGCACCAACAGTCAATGTCTTCAGGTTC-3)
were used for the first amplification of the nucleotide
sequence from position 131 to 642. The inner primers of
D1 and TS3 (5-TAACATCATCATGAGACAGAGC-3)
were used for the second amplification of the nucleo-
tide sequence from position 131 to 420. RT-PCR was
performed in a 50 μL mixture composed of 5 μL of
RNA, 1 μL of 20 μM of D1 and D2 primer, 40 U of
RNase inhibitor (Promega, Madison, WI, USA), 200 U
of MMLV (Promega), 2.5 U of Pfu DNA polymerase
(Protech, Taipei, Taiwan), 10 × PCR reaction buffer,
and 1 μL of 25 mM dNTP (Promega).
The following RT-PCR program was used: 37°C
for 1 hour, 94°C for 5 minutes, followed by 35 cycles
Table 1. Isolates of dengue-3 virus from Taiwan described in the study
Isolate designation Year of isolation Clinical status Fever Skin rash GenBank accession no. Genotype
0503-TW 2005 DF Y Y EF584513 –
0504-TW 2005 DF Y N EF584514 –
0601-TW 2006 DF Y N EF584515 III
0611-TW 2006 DF Y Y EF584516 III
0613-TW 2006 DF Y Y EF584517 III
0615-TW 2006 DF Y Y EF584518 III
0617-TW 2006 DF Y N EF584519 III
0622-TW 2006 DF Y N EF584520 III
0623-TW 2006 DHF Y Y EF584521 III
0629-TW 2006 DHF Y N EF584522 III
0630-TW 2006 DF Y Y EF584523 III
0638-TW 2006 DF Y Y EF584512 III
DF = dengue fever; DHF = dengue hemorrhagic fever; Y = yes; N = no.
of 95°C for 1 minute, 55°C for 30 seconds, 72°C for 
1 minute, and a final elongation step of 72°C for 
5 minutes. A second amplification reaction was per-
formed in a 100 μL mixture composed of 1/10 volume
of first PCR product, 10 × PCR reaction buffer, 5 U of
Pfu DNA polymerase, 1 μL of 25 mM dNTP and 2 μL
of 20 μM of D1 and TS3 primer. The nested PCR pro-
gram was: 94°C for 5 minutes, followed by 20 cycles
of 95°C for 1 minute, 55°C for 30 seconds, 72°C for 
1 minute, and a final elongation step of 72°C for 
5 minutes. Fragments of 290 bp were obtained from
the second amplification.
The 290-bp PCR products were purified using the
GFXTM PCR purification kit (Amersham Biosciences,
England). After purification, these PCR products were
sequenced directly using the ABI Prism Ready Reaction
Dideoxy Terminator Cycle Sequencing kit (Model
3730 version 3.4; Applied Biosystems, Foster City,
CA, USA).
Phylogenetic analysis
Alignment of these sequences was undertaken using
the Clustal method of DNASTAR MegAlign (DNAS-
TAR Inc., Madison, WI, USA). Phylogenetic trees
were constructed by the neighbor-joining method
with MEGA 3 (Molecular Evolutionary Genetics
Analysis, Version 3.0). The reliability of neighbor-
joined trees was estimated by bootstrap analysis. All
of the sequences studied in this study can be accessed
in GenBank. Their accession numbers are shown in
Table 1. Our sequences were compared to the other
dengue-3 strain sequences available in GenBank, and
aligned to the H87, a prototype strain of dengue-3.
The data on dengue-3 strains used in this study,
except the 2005 and 2006 Taiwan strains, are shown
in Table 2.
RESULTS
Nucleotide and amino acid sequence
analysis
The nucleotide sequences of these Taiwan dengue-3
strains, including four isolates from 1998, one isolate
from 1999, two isolates from 2005 and 10 isolates from
2006 are shown in Figure 1. Differences in the 290
nucleotides of the C gene among isolates within the
same year were 0% among 1998 isolates, 0.3% among
2005 isolates and 0–0.7% among 2006 isolates. In addi-
tion, nucleotide differences of 3.9%, 4.3%, 5.1–5.5% and
C gene analysis of dengue-3 viruses
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Table 2. Dengue-3 strains from GenBank used in the phylogenetic analysis described in this study
Virus strain GenBank accession no. Clinical status Location of isolation Year of isolation Genotype
98TW407 DQ675528 DF Taiwan 1998 III
98TW414 DQ675529 DF Taiwan 1998 III
98TW434 DQ675530 DF Taiwan 1998 III
98TW503 DQ675531 DF Taiwan 1998 III
99TW628 DQ675533 DF Taiwan 1999 III
PF89/27643 AY744677 French Polynesia 1989 I
PF89/320219 AY744678 French Polynesia 1989 I
PF90/3050 AY744679 French Polynesia 1990 I
PF90/3056 AY744680 French Polynesia 1990 I
PF90/6056 AY744681 French Polynesia 1990 I
PF92/2956 AY744682 French Polynesia 1992 I
PF92/2986 AY744683 French Polynesia 1992 I
PF92/4190 AY744684 French Polynesia 1992 I
PF94/136116 AY744685 French Polynesia 1994 I
H87 M93130 Philippines 1956 V
80-2 AF317645 China 1980 V
1243 AY099337 Martinique 1999 III
1266 AY099336 Sri Lanka 2000 III
TB55i AY858048 Indonesia 2004 I
TB16 AY858047 Indonesia 2004 I
PI64 AY858046 Indonesia 2004 I
BA51 AY858037 Indonesia 2004 I
den3_98 AY858039 Indonesia 1998 I
den3_88 AY858038 Indonesia 1998 I
3.5–3.9% were found in the 1998, 1999, 2005 and 2006
strains, respectively, compared with the prototype
dengue-3 strain (H87). Differences of 5.1–6.2% were
found between the 2005 strains and other Taiwan
strains. Furthermore, no base insertions or deletions
occurred in this 290-nucleotide region among these
strains. The differences in nucleotide sequence among
these Taiwan dengue-3 strains and H87 are shown in
Table 3.
The amino acid sequences of isolates from all of
the 1998 and 2005 strains and some of the 2006 strains
were completely the same. The amino acid sequences
encoded by the 290 nucleotides of the C gene are
shown in Figure 2. Two amino acid changes occurred
at the C103 (ArgLys) and C306 (LeuPhe) positions
in 1998 isolates. A ValAla change at C55 was found
in 2005 and 2006 isolates. Two LysArg changes
were also found at C244 and C289 in 2005 strains.
Except for the 0611 strain, which had one amino acid
change at C253, the amino acid sequences of the pro-
teins encoded by the C genes of 2006 epidemic isolates
were the same (Figure 2).
There was no significant difference in the changes
to gene and amino acid sequences between DF and
DHF cases in Taiwan in 2006. Two isolates (isolate num-
bers 0623-TW and 0629-TW) from DHF patients who
came from the same family and had symptoms on the
same day had 100% homology in the 290-nucleotide
C gene sequence. Both patients were dengue IgG
negative and IgM positive at the symptomatic stage.
Phylogenetic analysis
The nucleotide sequences generated in this study were
analyzed in combination with other dengue-3 gene
sequences available in GenBank. Table 2 shows the
data on all other dengue-3 strains analyzed in the
study, including clinical status, location and year of
isolation and GenBank accession number. A phyloge-
netic tree consisting of 17 Taiwan strains and 19 strains
from other countries was constructed and is shown
in Figure 3. The genetic relationships among world-
wide isolates were inferred by the neighbor-joining
method based on analysis of the 290-nucleotide C gene
sequences in GenBank. The phylogenetic analysis
showed that the 1998, 1999 and 2006 isolates belong
to genotype III, a group that also includes the 1243
strain (isolated in Martinique in 1999) and the 1266
strain (isolated in Sri Lanka in 2000). The dengue-3
isolates in 2005 (0503 and 0504) formed a clearly dis-
tinct genogroup, which differed from genotypes I, III
and V on the basis of analysis of the 290 nucleotides
of the C gene.
DISCUSSION
Nucleotide sequence analysis of DV can be used to
define genetic variation between strains of the same
serotype, follow geographical movement of the strains,
and thereby determine the evolutionary origin of 
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Figure 1. Alignment of the nucleotide sequences of Taiwan
dengue-3 strains and the H87 strain based on the 290 nucleotides
of the C gene.
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Table 3. Comparison of the nucleotide sequence (290 nucleotides) of the C genes of Taiwan dengue-3 strains and H87
% Nucleotide divergence
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
1 H87
2 98TW407 3.9
3 98TW414 3.9 0.0
4 98TW434 3.9 0.0 0.0
5 98TW503 3.9 0.0 0.0 0.0
6 98TW628 4.3 3.9 3.9 3.9 3.9
7 0503-TW 5.1 6.2 6.2 6.2 6.2 6.2
8 0504-TW 5.5 6.6 6.6 6.6 6.6 6.6 0.3
9 0601-TW 3.5 1.7 1.7 1.7 1.7 3.6 5.4 5.8
10 0611-TW 3.9 2.1 2.1 2.1 2.1 3.9 5.8 6.2 0.3
11 0613-TW 3.5 1.7 1.7 1.7 1.7 3.6 5.4 5.8 0.0 0.3
12 0615-TW 3.5 1.7 1.7 1.7 1.7 3.6 5.4 5.8 0.0 0.3 0.0
13 0617-TW 3.9 2.1 2.1 2.1 2.1 3.9 5.8 6.2 0.3 0.7 0.3 0.3
14 0622-TW 3.9 2.1 2.1 2.1 2.1 3.9 5.8 6.2 0.3 0.7 0.3 0.3 0.0
15 0623-TW 3.5 1.7 1.7 1.7 1.7 3.6 5.4 5.8 0.0 0.3 0.0 0.0 0.3 0.3
16 0629-TW 3.5 1.7 1.7 1.7 1.7 3.6 5.4 5.8 0.0 0.3 0.0 0.0 0.3 0.3 0.0
17 0630-TW 3.9 2.1 2.1 2.1 2.1 3.9 5.8 6.2 0.3 0.7 0.3 0.3 0.0 0.0 0.3 0.3
18 0638-TW 3.5 1.7 1.7 1.7 1.7 3.6 5.4 5.8 0.0 0.3 0.0 0.0 0.3 0.3 0.0 0.0 0.3
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Figure 2. Alignment of the amino acid sequences encoded by the
290 nucleotides of the C genes of Taiwan dengue-3 strains and
the H87 strain.
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Figure 3. Phylogenetic analysis of the C genes from 36 dengue-3
viruses. Viruses are listed by strain name in the GenBank data-
base and genotypes are indicated. Bootstrap values are given as
percentages and correspond to 1,000 replications.
epidemic DVs [12–16]. Our study of the C gene of the
dengue-3 viruses in circulation in recent years in
Taiwan showed that isolates of each year had the same
amino acid sequences, except for one isolate from
2006. Differences in the amino acid sequences encoded
by the C gene existed among genotype III isolates
from 1998, 1999 and 2006, in combination with the new
genotype in 2005, suggesting that the prevalent virus
changed every year. Whether the changes among the
genotype III isolates in each year were from sponta-
neous mutations or due to the introduction of new
strains each year could not be concluded in this
study. However, dengue-3 viruses from 2005 to 2006
were not from continuous spread of an epidemic strain
or re-emergence of the 2005 strains in the 2-year period
because there was a 5.4–6.2% difference in the 290
nucleotides of the C gene between 2005 and 2006
strains, and 2005 strains had a different genotype from
the 2006 strains. Most changes in nucleotides, com-
pared with H87 virus, occurred in the third codon
position and were non-synonymous mutations occur-
ring naturally in the C gene.
In contrast to DV serotypes 1, 2 and 4, there were
relatively few dengue-3 sequence data available in
GenBank. The five genotype (I–V) classification is bas-
ed on phylogenetic analysis of the envelope gene and
prM/M gene [5–7]. Phylogenetic study of the C gene
has been undertaken for DVs not of serotype 3 [18,19].
The results of our C gene phylogenetic analysis show
the same grouping as the results of E gene analysis on
dengue-3 strains [7]. However, studies on long se-
quences, such as the E gene (1,450 nucleotides) or the
PrM/M/E gene (2,550 nucleotides), require virus
culture and cloning. Our method of C gene (290
nucleotides) analysis had an advantage of rapid
genotyping because typing results can be obtained by
direct PCR sequencing of blood specimens. Phyloge-
netic analysis of the C genes of these Taiwan dengue-
3 strains and other global strains showed that the
1998, 1999 and 2006 Taiwan strains belong to geno-
type III. Genotype III also included the 1243 and 1266
strains, which were isolated in Martinique in 1999
and Sri Lanka in 2000, respectively.
The 2005 isolates (0503 and 0504) formed a clearly
distinct genogroup from the 1998, 1999 and 2006
Taiwan strains, which obviously differed from geno-
types I, III and V in the C gene analysis. To determine
whether the Taiwan dengue-3 isolates in 2005 were of
genotypes II, IV or a new genotype requires further
study of other genes and comparison with global 
isolates of known genotypes. The genotype changes
in dengue-3 virus in Taiwan from 1998 to 2006
showed a different pattern from the observation in
Thailand where there were extinctions and rapid
emergence of strains of dengue-3 virus during an
inter-epidemic period, possibly due to a genetic bot-
tleneck condition [6].
Regarding the pathogenesis of DHF/DSS, (1) im-
mune enhancement caused by repeat or co-infection
with a second dengue virus of different serotype [20],
and (2) variation in viral virulence, where the more
severe disease was due to the greater virulence of
specific strains [13,21], has been proposed. Previous
studies have shown that mutations in the dengue ge-
nome may be associated with changes in virulence
[22,23]. Although the possibility that the determinant
of virulence is not located in the C gene cannot be
excluded, our results showed that there were no con-
sistent differences in the sequence of the 290 nucle-
otides of the C gene between eight DF and two DHF
isolates in 2006. Two isolates (isolate numbers: 0623-
TW and 0629-TW) from DHF patients who came from
the same family and had symptoms on the same day
had 100% homology in the 290-nucleotide sequence.
This implied that the two patients were infected by the
same dengue-3 strain in which viral virulence may
play a role in the mechanism of DHF. Because both of
the patients had primary dengue infection, an immune
enhancement effect is unlikely to be the cause.
In summary, this study indicates that isolates of
the 1998, 1999 and 2006 Taiwan dengue-3 epidemics are
phylogenetically related and belong to the genotype
III group of viruses. It was also noted that the 2005
Taiwan dengue-3 isolates (0503 and 0504) belong to
another genotype. Phylogenetic analysis is helpful to
elucidate whether there is a continuation of out-
breaks in consecutive years, to recognize the possibil-
ity of re-emergence of endemic DV, and to identify
the introduction of strains from other countries.
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